Dr Keeling comments:
We are aware that vascular 'abnormalities' may be produced by the casual treatment of tissues. The lungs in this case were fixed before blocks were taken for histological examination and we note that Moffat (1956) was unable to produce vascular 'lesions' when tissues were treated in this way; nor were we, on re-examination of semiserial sections of the lungs, able to find evidence of local vessel damage, thus excluding reported causes of artefact. Archives, 1978, 53, 598) who found that theophylline therapy facilitated the weaning of infants from mechanical ventilation when apnoea and bradycardia occurred at low IMV rates. We have used this combination therapy in 2 infants with hyaline membrane disease (1620 g, 32 weeks' gestation; 2000 g, 34 weeks' gestation). Theophylline serum concentrations were closely monitored, and all were in the therapeutic range (6 to 11 mg/i). Both infants were severely ill. Each had bilateral pneumothoraces requiring chest tube drainage. Both developed significant apnoea and bradycardia at IMV rates less than 5, necessitating increased ventilatory support primarily in the form of repeated bagging during apnoeic episodes. The infants had dramatic responses to treatment with theophylline, and we were able to extubate both infants within 48 hours. We too believe that theophylline can aid in weaning infants from ventilators when apnoea and bradycardia occur at low IMV rates. Theophylline can be beneficial not only for low birthweight infants but also for those in whom rapid extubation or a reduction in mean intrathoracic pressure is desirable. Our infants with pneumothoraces are good examples, and others (such as those with pneumopericardium) come readily to mind.
Detection of phenylketonuria
Sir, Guthrie testing is performed at this hospital on blood samples received from the whole of Scotland, from children aged 6 to 14 days (Stevenson and Kennedy, 1974) . Samples are assayed for phenylalanine, tyrosine, methionine, leucine, and galactose, blood samples being collected by hospitals or health visitors as appropriate, and a check on samples received compared with the number of registered births by the district medical officer.
Theoretically, therefore, all children should be included in this national scheme; although in practice the percentage ofchildren sampled varies from 93-99 % (Clayton, 1976) .
In a recent search for the PKU cards of children born in Glasgow of known birth dates for another purpose, a surprising number of samples had either never been received by the hospital, or had not been taken within the recommended time of 6 to 14 days. Of 1000 sequential samples received from the Glasgow area during 4 weeks in 1977, in 4.2% of cases the child was 6 days old when the specimen was assayed, and must therefore have been less than 6 days old when the sample was taken. 93.8% of samples were taken at an 'acceptable' age of 7 to 21 days old; but in the remaining 2% of cases, the child was over 3 weeks old before the test was done; in 0.8 % of cases, representing 100 samples per year in Glasgow, or 700 in Scotland, the child was imore than 2 months-in some cases, as much as 7 months old.
Obviously in these cases the value of the test is much reduced, with the possibility that permanent brain damage would already have occurred before it was performed. This has two consequences-firstly, doctors who are working with sick young children should be aware that they may not have had inborn metabolic errors excluded by the National Screening Programme; secondly, if neonatal screening is to be extended to other conditions of personal or economic importance, such as hypothyroidism or lead poisoning, a truly fail-safe and universal screening programme would be needed, if it is to justify its cost. (Archives, 1978, 53, 250) . Although they stated that 'all other common causes of neonatal jaundice had been excluded', the ABO set-up (blood group of baby A and the mother 0) which is the most common cause of jaundice in the newborn, was present. In ABO incompatibility, the direct Coombs's test is usually negative. Therefore this possibility should be ruled out before ascribing the neonatal jaundice to thalassaemia. I should also like to add that among our 90 patients with thalassaemia major (until 1970) pallor and distended abdomen were noticed at birth in two, at 17 days of age in one, at 20 days in one, at 30 days in two, and at about 40 days in two; the observation of splenomegaly as early as The letter from Prof. S. Ozsoylu raises the possibility that the neonatal jaundice could have been due to ABO incompatibility.
However there was evidence of a moderate haemolytic process with Hb level of 13 g/dl in the 5th day, and the jaundice was first noted on the 3rd day, while in ABO incompatibility there is usually little or no evidence of a haemolytic process, and hyperbilirubinaemia appears usually within 24 hours of birth. Moreover, microspherocytosis, a prominent feature of ABO haemolytic disease, was absent.
The direct Coombs's test on the infant's erythrocytes was negative, while in our laboratory, as in others, a weakly positive reaction in ABO haemolytic disease is common. Finally when there is ABO incompatibility it is our custom to test the eluate from the erythrocytes of the affected newborn with A (or B) adult cell. This reaction was negative, and not strongly positive as found usually in ABO haemolytic disease. ABO haemolytic disease cannot be ruled out with certainty in this case but the evidence makes this diagnosis highly improbable.
Prof. Ozsoylu comments that in the population under his care Cooley's anaemia often presented early. In the last year we diagnosed 80 new cases of Cooley's anaemia due to homozygous 1O-thalassaemia. Anearlypresentation with criteria such as symptomatic anaemia at 75-90 days was observed in 30 % of cases, but the severe anaemia (Hb < 6 g/dl) at 60 days as seen in our patient was rather uncommon. Splenomegaly in cases with earlier presentation is an unusual feature in this area. (Archives, 1978, 53, 580 
